Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
297
-
Total 13F shares, excl. options
-
65.8M
-
Shares change
-
+1.16M
-
Total reported value, excl. options
-
$6.08B
-
Value change
-
+$130M
-
Put/Call ratio
-
0.85
-
Number of buys
-
146
-
Number of sells
-
-160
-
Price
-
$92.48
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q3 2021
389 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2021.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 297 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.8M shares
of 106M outstanding shares and own 62.25% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.48M shares), JANUS HENDERSON GROUP PLC (7.4M shares), SANDS CAPITAL MANAGEMENT, LLC (5.57M shares), BlackRock Inc. (4.76M shares), FMR LLC (4.15M shares), Capital Research Global Investors (2.54M shares), Avoro Capital Advisors LLC (2.5M shares), Bank of New York Mellon Corp (1.96M shares), Point72 Asset Management, L.P. (1.85M shares), and STATE STREET CORP (1.79M shares).
This table shows the top 297 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.